DRKS00022249
Recruiting
Not Applicable
Examination of the activation of thrombocytes and placental inflammasome in pre-eclampsia
niversitätsklinikum Leipzig0 sites66 target enrollmentJuly 24, 2020
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- healthy pregnant women
- Sponsor
- niversitätsklinikum Leipzig
- Enrollment
- 66
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with established pre\-eclampsia according to national Guidelines and healthy controls with planed cesarean delivery
Exclusion Criteria
- •acute Inflammation/infection of the mother or fetus, fetal abnormalities, autoimmune diseases of the mother or coronary disease, hypertonia or diabetes outside of the pregnancy, pregnancy associated conditions other than pre\-eclampsia (e.g. diabetes, placenta praevia), non\-singleton pregnancy.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Platenza Tablets for Dengue feverCTRI/2018/02/011789The Himalaya Drug Company40
Recruiting
Not Applicable
Pioneering study on activated platelets in thrombus and embolus formation among stroke patients joint study between Yokohama and MoriokaJPRN-UMIN000022911Iwate Medical University100
Completed
Phase 2
Platenza Tablets for Dengue feverHealth Condition 1: null- Dengue FeverCTRI/2018/03/012738The Himalaya Drug Company60
Completed
Phase 2
Tablets for dengueCTRI/2018/03/012697The Himalaya Drug Company Ltd60
Recruiting
Not Applicable
Biomarkers of thrombocyte activation as predictive factor for hemorrhagic complications of strokes occurring under platelet aggregation inhibitioI63I61Cerebral infarctionIntracerebral haemorrhageDRKS00030574Klinik für Neurologie, Universitätsklinikum Frankfurt, Goethe Universität100